Local and Systemic STAT3 and p65 NF-KappaB Expression as Progression Markers and Functional Targets for Patients With Cervical Cancer-Reference-Cited by-同舟云学术

Local and Systemic STAT3 and p65 NF-KappaB Expression as Progression Markers and Functional Targets for Patients With Cervical Cancer

Published:2020-11-19 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Rossetti Renata A. M.,da Silva-Junior Ildefonso A.,Rodríguez Gretel R.,Alvarez Karla L. F.,Stone Simone C.,Cipelli Marcella,Silveira Caio R. F.,Beldi Mariana Carmezim,Mota Giana R.,Margarido Paulo F. R.,Baracat Edmund C.,Uno Miyuki,Villa Luisa L.,Carvalho Jesus P.,Yokochi Kaori,Rosa Maria Beatriz S. F.,Lorenzi Noely P.,Lepique Ana Paula

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference47 articles.

1. Cervical cancer: A global health crisis;Small;Cancer,2017

2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide;Walboomers;J Pathol,1999

3. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease;Arbyn;Int J Cancer,2012

4. HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models;Stone;Immun Inflammation Dis,2014

5. M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells;Heusinkveld;J Immunol,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis;Critical Reviews in Oncology/Hematology;2024-05

2. Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response;Medicinal Research Reviews;2023-03-23

3. Arsenic-induced differential inflammatory responses in mouse thymus involves NF-κB/STAT-3 disruption, Treg bias and autophagy activation;Life Sciences;2023-02

4. Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy;Frontiers in Immunology;2022-11-03